Reported Earnings • Apr 17
Full year 2025 earnings released: CN¥0.29 loss per share (vs CN¥0.48 loss in FY 2024) Full year 2025 results: CN¥0.29 loss per share (improved from CN¥0.48 loss in FY 2024). Revenue: CN¥171.0m (down 1.1% from FY 2024). Net loss: CN¥22.5m (loss narrowed 41% from FY 2024). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Tillkännagivande • Apr 17
Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 08, 2026 Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 08, 2026, at 14:30 China Standard Time. Location: 1F, Building 1, Yard No. 8, Linglan Road, Haidian District, Beijing China Tillkännagivande • Mar 30
Beijing Bohui Science & Technology Co., Ltd to Report Q1, 2026 Results on Apr 23, 2026 Beijing Bohui Science & Technology Co., Ltd announced that they will report Q1, 2026 results on Apr 23, 2026 Tillkännagivande • Dec 26
Beijing Bohui Science & Technology Co., Ltd to Report Fiscal Year 2025 Results on Apr 17, 2026 Beijing Bohui Science & Technology Co., Ltd announced that they will report fiscal year 2025 results on Apr 17, 2026 Reported Earnings • Oct 24
Third quarter 2025 earnings released: EPS: CN¥0.037 (vs CN¥0.16 loss in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.037 (up from CN¥0.16 loss in 3Q 2024). Revenue: CN¥63.7m (up 19% from 3Q 2024). Net income: CN¥2.76m (up CN¥15.3m from 3Q 2024). Profit margin: 4.3% (up from net loss in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings. New Risk • Oct 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 64% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change). Tillkännagivande • Sep 30
Beijing Bohui Science & Technology Co., Ltd to Report Q3, 2025 Results on Oct 24, 2025 Beijing Bohui Science & Technology Co., Ltd announced that they will report Q3, 2025 results on Oct 24, 2025 Reported Earnings • Aug 23
Second quarter 2025 earnings released: CN¥0.14 loss per share (vs CN¥0.19 loss in 2Q 2024) Second quarter 2025 results: CN¥0.14 loss per share (improved from CN¥0.19 loss in 2Q 2024). Revenue: CN¥29.3m (up 8.5% from 2Q 2024). Net loss: CN¥12.5m (loss narrowed 16% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings. Tillkännagivande • Jun 30
Beijing Bohui Science & Technology Co., Ltd to Report First Half, 2025 Results on Aug 22, 2025 Beijing Bohui Science & Technology Co., Ltd announced that they will report first half, 2025 results on Aug 22, 2025 Tillkännagivande • May 08
Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 29, 2025 Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 29, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China Tillkännagivande • Apr 25
Beijing Bohui Science & Technology Co., Ltd announced that it expects to receive CNY 300 million in funding Beijing Bohui Science & Technology Co., Ltd announced a private placement to issue common shares for gross proceeds of not more than CNY 300,000,000 on April 23, 2025. The transaction has been approved by 16th meeting of the 4th Board of Directors. The shares issued to specific investors shall not be transferred within 6 months from the end of the issuance; if the investors fall under the circumstances specified in Article 57, Paragraph 2 of the "Administrative Measures for the Registration of Securities Issuance by Listed Companies," the shares they subscribe to shall not be transferred within 18 months from the end of the issuance. Reported Earnings • Apr 19
Full year 2024 earnings released: CN¥0.48 loss per share (vs CN¥0.54 loss in FY 2023) Full year 2024 results: CN¥0.48 loss per share (improved from CN¥0.54 loss in FY 2023). Revenue: CN¥172.8m (down 9.9% from FY 2023). Net loss: CN¥38.5m (loss narrowed 11% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 64% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change). Tillkännagivande • Mar 28
Beijing Bohui Science & Technology Co., Ltd to Report Q1, 2025 Results on Apr 24, 2025 Beijing Bohui Science & Technology Co., Ltd announced that they will report Q1, 2025 results on Apr 24, 2025 Reported Earnings • Mar 02
Full year 2024 earnings released: CN¥0.48 loss per share (vs CN¥0.54 loss in FY 2023) Full year 2024 results: CN¥0.48 loss per share (improved from CN¥0.54 loss in FY 2023). Revenue: CN¥172.8m (down 9.9% from FY 2023). Net loss: CN¥38.6m (loss narrowed 11% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance. Tillkännagivande • Dec 27
Beijing Bohui Science & Technology Co., Ltd to Report Fiscal Year 2024 Results on Apr 18, 2025 Beijing Bohui Science & Technology Co., Ltd announced that they will report fiscal year 2024 results on Apr 18, 2025 Reported Earnings • Oct 23
Third quarter 2024 earnings released: CN¥0.16 loss per share (vs CN¥0.14 loss in 3Q 2023) Third quarter 2024 results: CN¥0.16 loss per share (further deteriorated from CN¥0.14 loss in 3Q 2023). Revenue: CN¥53.7m (up 8.3% from 3Q 2023). Net loss: CN¥12.6m (loss widened 22% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance. Tillkännagivande • Oct 09
Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces an Equity Buyback for CNY 50 million worth of its shares. Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 16.18 per share. The purpose of the program is to use the repurchased shares for employee stock ownership plans or equity incentives at an appropriate time in the future. The program will be funded from company's own funds. The plan will be valid for 12 months. Tillkännagivande • Sep 30
Beijing Bohui Science & Technology Co., Ltd to Report Q3, 2024 Results on Oct 23, 2024 Beijing Bohui Science & Technology Co., Ltd announced that they will report Q3, 2024 results on Oct 23, 2024 Reported Earnings • Aug 22
Second quarter 2024 earnings released: CN¥0.19 loss per share (vs CN¥0.22 loss in 2Q 2023) Second quarter 2024 results: CN¥0.19 loss per share (improved from CN¥0.22 loss in 2Q 2023). Revenue: CN¥27.0m (down 16% from 2Q 2023). Net loss: CN¥14.8m (loss narrowed 25% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Tillkännagivande • Jun 29
Beijing Bohui Science & Technology Co., Ltd to Report First Half, 2024 Results on Aug 22, 2024 Beijing Bohui Science & Technology Co., Ltd announced that they will report first half, 2024 results on Aug 22, 2024 Tillkännagivande • Apr 26
Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 15, 2024 Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 15, 2024, at 14:00 China Standard Time. Location: Building 8, Yard No. 5, Rendong Road, Haidian District, Beijing China Reported Earnings • Apr 18
Full year 2023 earnings released: CN¥0.76 loss per share (vs CN¥0.50 loss in FY 2022) Full year 2023 results: CN¥0.76 loss per share (further deteriorated from CN¥0.50 loss in FY 2022). Revenue: CN¥191.8m (up 17% from FY 2022). Net loss: CN¥43.2m (loss widened 52% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Tillkännagivande • Mar 29
Beijing Bohui Science & Technology Co., Ltd to Report Q1, 2024 Results on Apr 25, 2024 Beijing Bohui Science & Technology Co., Ltd announced that they will report Q1, 2024 results on Apr 25, 2024 Reported Earnings • Feb 28
Full year 2023 earnings released: CN¥0.74 loss per share (vs CN¥0.50 loss in FY 2022) Full year 2023 results: CN¥0.74 loss per share (further deteriorated from CN¥0.50 loss in FY 2022). Revenue: CN¥181.4m (up 11% from FY 2022). Net loss: CN¥42.1m (loss widened 48% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance. New Risk • Jan 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 55% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.3% average weekly change). Board Change • Jan 10
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Feng Lin was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Tillkännagivande • Dec 29
Beijing Bohui Science & Technology Co., Ltd to Report Fiscal Year 2023 Results on Apr 18, 2024 Beijing Bohui Science & Technology Co., Ltd announced that they will report fiscal year 2023 results on Apr 18, 2024 Reported Earnings • Oct 20
Third quarter 2023 earnings released: CN¥0.19 loss per share (vs CN¥0.071 loss in 3Q 2022) Third quarter 2023 results: CN¥0.19 loss per share (further deteriorated from CN¥0.071 loss in 3Q 2022). Revenue: CN¥49.6m (up 5.3% from 3Q 2022). Net loss: CN¥10.3m (loss widened 155% from 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Tillkännagivande • Sep 30
Beijing Bohui Science & Technology Co., Ltd to Report Q3, 2023 Results on Oct 19, 2023 Beijing Bohui Science & Technology Co., Ltd announced that they will report Q3, 2023 results on Oct 19, 2023 Reported Earnings • Aug 25
Second quarter 2023 earnings released: CN¥0.31 loss per share (vs CN¥0.36 loss in 2Q 2022) Second quarter 2023 results: CN¥0.31 loss per share (improved from CN¥0.36 loss in 2Q 2022). Revenue: CN¥32.0m (up 228% from 2Q 2022). Net loss: CN¥19.8m (loss narrowed 6.4% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 12
Full year 2022 earnings released: CN¥0.50 loss per share (vs CN¥0.87 profit in FY 2021) Full year 2022 results: CN¥0.50 loss per share (down from CN¥0.87 profit in FY 2021). Revenue: CN¥164.0m (down 43% from FY 2021). Net loss: CN¥28.4m (down 158% from profit in FY 2021). Board Change • Nov 16
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Guangzhi Wang was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Oct 25
Third quarter 2022 earnings released: CN¥0.071 loss per share (vs CN¥0.02 profit in 3Q 2021) Third quarter 2022 results: CN¥0.071 loss per share (down from CN¥0.02 profit in 3Q 2021). Revenue: CN¥47.1m (down 8.4% from 3Q 2021). Net loss: CN¥4.04m (down 465% from profit in 3Q 2021). Reported Earnings • Aug 26
Second quarter 2022 earnings released: CN¥0.36 loss per share (vs CN¥0.35 profit in 2Q 2021) Second quarter 2022 results: CN¥0.36 loss per share (down from CN¥0.35 profit in 2Q 2021). Revenue: CN¥9.76m (down 89% from 2Q 2021). Net loss: CN¥21.2m (down 204% from profit in 2Q 2021). Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥26.69, the stock trades at a trailing P/E ratio of 31.5x. Average trailing P/E is 52x in the Software industry in China. Total loss to shareholders of 33% over the past year. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Apr 12
Full year 2021 earnings released: EPS: CN¥0.87 (vs CN¥0.93 in FY 2020) Full year 2021 results: EPS: CN¥0.87. Revenue: CN¥287.1m (flat on FY 2020). Net income: CN¥49.2m (up 5.9% from FY 2020). Profit margin: 17% (up from 16% in FY 2020). Reported Earnings • Feb 28
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: CN¥1.86 (up from CN¥0.93 in FY 2020). Revenue: CN¥405.9m (up 41% from FY 2020). Net income: CN¥136.1m (up 193% from FY 2020). Profit margin: 34% (up from 16% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Reported Earnings • Oct 25
Third quarter 2021 earnings released: EPS CN¥0.02 (vs CN¥0.02 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥51.3m (up 20% from 3Q 2020). Net income: CN¥1.11m (down 15% from 3Q 2020). Profit margin: 2.2% (down from 3.1% in 3Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Aug 20
Second quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.30 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥89.2m (up 6.3% from 2Q 2020). Net income: CN¥20.4m (up 21% from 2Q 2020). Profit margin: 23% (up from 20% in 2Q 2020). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Aug 03
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥38.88, the stock trades at a trailing P/E ratio of 47.5x. Average trailing P/E is 51x in the Software industry in China. Total loss to shareholders of 51% over the past year. Valuation Update With 7 Day Price Move • Jun 02
Investor sentiment improved over the past week After last week's 23% share price gain to CN¥43.66, the stock trades at a trailing P/E ratio of 53.3x. Average trailing P/E is 51x in the Software industry in China. Reported Earnings • Apr 20
Full year 2020 earnings released: EPS CN¥0.93 (vs CN¥1.20 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥287.9m (up 4.8% from FY 2019). Net income: CN¥46.4m (down 8.8% from FY 2019). Profit margin: 16% (down from 19% in FY 2019). The decrease in margin was driven by higher expenses. Is New 90 Day High Low • Feb 04
New 90-day low: CN¥39.01 The company is down 37% from its price of CN¥61.67 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 2.0% over the same period. Is New 90 Day High Low • Jan 07
New 90-day low: CN¥43.49 The company is down 35% from its price of CN¥67.18 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 1.0% over the same period. Is New 90 Day High Low • Dec 15
New 90-day low: CN¥51.69 The company is down 22% from its price of CN¥66.50 on 16 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 5.0% over the same period. Is New 90 Day High Low • Nov 27
New 90-day low: CN¥58.65 The company is down 24% from its price of CN¥77.24 on 28 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 11% over the same period. Is New 90 Day High Low • Oct 30
New 90-day low: CN¥61.80 The company is down 24% from its price of CN¥81.00 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 12% over the same period. Reported Earnings • Oct 26
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥55.2m, up 6.4% from the prior year. Total revenue was CN¥287.5m over the last 12 months, up 3.8% from the prior year. Tillkännagivande • Oct 19
Beijing Bohui Science & Technology Co., Ltd. to Report Q3, 2020 Results on Oct 20, 2020 Beijing Bohui Science & Technology Co., Ltd. announced that they will report Q3, 2020 results on Oct 20, 2020 Tillkännagivande • Jul 09
Beijing Bohui Science & Technology Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020 Beijing Bohui Science & Technology Co., Ltd. announced that they will report first half, 2020 results on Aug 25, 2020